Home›Stock Screener›Suraksha Diagnostic

Suraksha Diagnostic Share Price Today | Stock Price & Suraksha Diagnostic Share Screener

SURAKSHA Healthcare Service Provider
Live Share Price NSE
₹331.85
▼ -18.30 (-5.23%)
2026-10-05 00:00:00
Live Share Price BSE
₹331.05
▼ -19.20 (-5.48%)
2026-10-05 00:00:00

As of October 5, 2026, the live Suraksha Diagnostic share price (NSE: SURAKSHA) is ₹331.85 on NSE and ₹331.05 on BSE, down 5.23% from the previous close, with shares trading between ₹330.50 and ₹354.00 in today's trading session, and a 52-week range of ₹227.95–₹356.00. Check Suraksha Diagnostic 52-week for the annual price range and momentum. Use the Suraksha Diagnostic stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Suraksha Diagnostic opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹66 and net income of ₹7, with EBITDA of ₹20, an operating margin of 29.0% and a profit margin of 10.6%.

Suraksha Diagnostic Market Cap ₹1,355.66 Cr.
SURAKSHA P/E Ratio (TTM) 40.64
Suraksha Diagnostic P/B Ratio 5.71
EPS (TTM) ₹5.97
Dividend Yield -
Debt to Equity 0.46
SURAKSHA 52 Week High ₹356.00
Suraksha Diagnostic 52 Week Low ₹227.95
Operating Margin 29.00%
Profit Margin 10.61%
SURAKSHA Revenue (TTM) ₹66.00
EBITDA ₹20.00
Net Income ₹7.00
Total Assets ₹334.00
Total Equity ₹210.00

Suraksha Diagnostic Share Price Chart

Track the current stock price of Suraksha Diagnostic with an interactive chart. Analyse SURAKSHA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Suraksha Diagnostic stock quote in one place.

The quote of ₹331.85 sits between the 52-week low of ₹227.95 and the 52-week high of ₹356.00, and the latest session moved -5.23% from the previous close.

Suraksha Diagnostic Company Profile - Fundamental Screener

Screen Suraksha Diagnostic company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SURAKSHA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE877V01027.

Company Details

Classification

Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E

Identifiers and Leadership

ISIN INE877V01027

Suraksha Diagnostic Balance Sheet Screener

Screen SURAKSHA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹334, up from ₹300 in 2024.

Latest statistics put total assets at ₹334 and shareholder funds at ₹210, with a leverage ratio of 0.46.

Item 2025 2024 2023 2022 2021 2020

Assets

Total Assets 334 300 281 0 171 173
Current Assets 47 72 68 0 27 28
Fixed Assets 223 212 195 0 119 128

Liabilities

Total Liabilities 0 0 0 0 0 0
Current Liabilities 81 82 87 0 20 19
Non-Current Liabilities 0 0 0 0 0 0

Shareholders' Equity

Total Equity 210 179 156 0 126 120
Share Capital 10 9 9 0 9 9
Reserves & Surplus 201 171 147 0 118 111

Suraksha Diagnostic Income Statement Screener - Profit & Revenue Analysis

Screen Suraksha Diagnostic income statement and profit fundamentals. Analyze SURAKSHA quarterly results. Suraksha Diagnostic reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Mar, revenue was ₹66 and net profit was ₹7, equal to earnings per unit of ₹1.42, at an operating margin of 29%.

In that period expenses were ₹46, interest cost ₹2 and tax ₹2. The next period listed, 2025-Jun, shows revenue of ₹74 and net profit of ₹9.

Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 66 74 80 78 56 62 68 60 53 61 53
Expenses 46 49 55 55 37 40 44 41 37 39 37

Operating Costs and Margins

EBITDA 20 25 25 24 20 22 25 19 16 21 16
Operating Profit % 29.00% 33.00% 31.00% 30.00% 34.00% 34.00% 35.00% 31.00% 28.00% 35.00% 30.00%
Depreciation 9 10 10 11 8 9 9 9 8 8 8
Interest 2 3 3 3 2 2 2 2 2 3 2

Profit and Earnings

Profit Before Tax 9 13 12 10 9 11 14 8 5 11 6
Tax 2 3 3 3 3 3 4 2 1 3 2
Net Profit 7 9 9 7 6 8 10 6 4 8 5
EPS 1.42 1.80 1.73 1.44 1.22 1.49 1.94 1.18 1.17 2.44 0.87

Suraksha Diagnostic Cash Flow Screener - Liquidity Fundamentals

Screen SURAKSHA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹63.

Over the same period, investing activities used ₹40 and financing activities used ₹24.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 63 61 44 42 24 31
Investing Activities -40 -35 -21 -44 -28 -20

Financing and Net Cash

Financing Activities -24 -25 -24 1 3 -10
Net Cash Flow 0 0 -1 0 -1 1

Suraksha Diagnostic Shareholding Pattern Screener

See Suraksha Diagnostic shareholding pattern with promoter, FII, and DII holdings. Check Suraksha Diagnostic promoter holding and ownership changes for SURAKSHA on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 48.78%, foreign institutions 14.46%, domestic institutions 22.05% and the public 13.52%, spread across 87,275 shareholders.

The shareholder count was 87,275 in 2025-Mar, compared with 79,670 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Jul 2024-Nov 2024-Dec

Promoter Holding

Promoter Holding 48.78% 48.88% 48.98% 49.00% 72.41% 61.06% 48.78%

Institutional Investors

FII Holding 14.46% 13.95% 13.72% 13.46% 0.00% 0.00% 15.39%
DII Holding 22.05% 22.37% 21.98% 22.57% 0.00% 0.00% 20.44%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 13.52% 13.08% 12.96% 12.60% 0.00% 0.00% 14.08%
Other Holding 1.19% 1.71% 2.36% 2.38% 27.59% 38.94% 1.31%
Shareholder Count 87,275 79,670 75,304 70,963 10 10 10

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Suraksha Diagnostic. Suraksha Diagnostic dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Suraksha Diagnostic.

Suraksha Diagnostic Stock Index Membership - Nifty & Sensex

See which indices include Suraksha Diagnostic stock. Check SURAKSHA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 4 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX BSEIPO, BSE INDEX SMLCAP, NIFTY IPO.

Complete Index List

BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY IPO

Suraksha Diagnostic Market Events Screener - Corporate Actions

Get Suraksha Diagnostic corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Suraksha Diagnostic stock events that may affect SURAKSHA share price, along with derivatives, futures and options activity and sector gainers.

7 corporate actions are listed, the most recent entry being Annual General Meeting dated .

It is followed by Quarterly Result Announcement dated February 5, 2026 and Quarterly Result Announcement dated November 10, 2025.

Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -7.42%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 9.06%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 0.50%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -4.71%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 3.91%
2025-02-08 2025-02-08 Quarterly Result Announcement NA 11.34%
2024-12-20 2024-12-20 Quarterly Result Announcement NA -0.81%

Suraksha Diagnostic Competitors Screener - Peer Stocks Comparison

Screen SURAKSHA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 21,919 41.66 2,555 11.28% 492 35.09
Vijaya Diagnostic Centre 9,293 59.48 700 23.06% 144 33.11
Metropolis Healthcare 9,143 223.40 1,346 10.64% 146 36.62
Thyrocare Technologies 5,592 42.11 702 20.80% 91 32.37
Nephrocare Health Services 5,347 74.12 770 33.97% 67 45.61
Krsnaa Diagnostics 1,906 23.95 743 16.70% 78 32.85
Suraksha Diagnostic 1,356 40.64 256 15.11% 31 45.20
One Global Service Provider 1,104 17.46 148 134.60% 19 40.81
3B BlackBio DX 1,103 18.92 112 28.72% 48 42.27
Sastasundar Ventures 916 30.92 1,171 -18.47% -134 52.26

Suraksha Diagnostic Company Announcements - News & Reports Screener

Screen SURAKSHA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 3, 2026.

The next most recent announcements are dated March 2, 2026 and March 2, 2026.

Date Update Actions
2026-10-03 Closure of Trading Window -
2026-03-02 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-03-02 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) -
2026-02-12 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-02-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-02-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-05 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-02-05 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-02-05 Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2025 Along With The Limited Review Report. -
2026-02-05 Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Thursday 05 February 2026 -
2026-01-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-01-27 Board Meeting Intimation for The Board Meeting To Be Held On Thursday 05 February 2026 -
2026-01-16 Intimation Regarding Change In Name Of Statutory Auditor Of The Company Pursuant To Conversion Into LLP -
2026-01-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-22 Closure of Trading Window -
2025-12-08 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2025-12-02 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2025-11-14 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2025-11-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2025-11-11 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹331.85, within a 52-week range of ₹227.95 to ₹356.00. The P/E ratio is 40.64 and the P/B ratio is 5.71, with earnings per unit of ₹5.97. Market capitalisation stands at ₹1,355.66 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 6 balance sheet periods, 11 income statement periods, 6 cash flow years and 7 shareholding periods. Information is provided for research and is not investment advice.